Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Baroness Walmsley, and are more likely to reflect personal policy preferences.
Baroness Walmsley has not introduced any legislation before Parliament
Baroness Walmsley has not co-sponsored any Bills in the current parliamentary sitting
The National Institute for Health and Care Excellence (NICE) published a strategy in March 2025 setting out a collective ambition for improving uptake and adoption of NICE guidance by the health and care system over the next three years. The strategy aims to improve the uptake and adoption of NICE guidance in priority areas which align with the National Health Service 10-Year Health Plan by 10% by March 2029. This includes guidance on cardiovascular disease and diabetes, further details on which can be found on the NICE website.
In 2023, NHS England published a renal services transformation toolkit to support earlier identification of chronic kidney disease and more joined up services. Eight commissioned regional renal clinical networks are implementing this toolkit, in collaboration with providers. The regional networks are designed to improve care for kidney patients by standardizing treatment, reducing health inequalities, and promoting best practices, including for medical therapy use, across hospitals, commissioners, and specialists.
NHS England is delivering a comprehensive programme to improve the diagnosis, treatment, and outcomes of people with kidney disease. In 2023, NHS England published a renal services transformation toolkit to support earlier identification of chronic kidney disease and more joined up services. These changes are intended to make it easier to deliver improvements along the whole patient pathway, including earlier diagnosis and treatment, that can potentially prevent or delay the need for dialysis and transplant further downstream in the pathway.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing clinical guidance and quality standards. NICE’s guidance on chronic kidney disease includes guidance on the use of annual urine albumin-creatine ratio tests as the preferred method to detect and monitor kidney disease. The guidance is available on the NICE website.
The Tobacco Advertising and Promotion Act 2002 prohibits any advertisements whose purpose or effect is to promote a tobacco product. The Advertising Standards Authority’s rules state that marketing communications for cigarette filters should not encourage people to start smoking or increase their consumption.
The Tobacco and Vapes Bill restates the restrictions on the advertising of tobacco products. We have no current plans to introduce additional restrictions on the advertising of filters through the bill.